According to an international multicenter study, CD2-negative mast cells are associated with significantly reduced overall survival in patients with SM. Patients with CD2-negative mast cells have ...
Poster Presentation to Spotlight Ongoing Phase 1 Clinical Trial of EVOLVE104Oral and Poster Presentations to Highlight Preclinical Data ...
Investigational microbiota-based live therapeutic RBX2660 was found to be safe and effective at reducing Clostridioides difficile (C difficile) recurrence, said Paul Feuerstadt, MD, assistant clinical ...
A study reveals a molecule that triggers cancer recognition in natural killer (NK) cells. The study defines an important role for CD2 in stimulating NK cell responses to therapeutic antibodies. The ...
Figure 2: Bar graph showing the relative proportions (percentage of total recombinant CD2 produced which folds as an intertwined dimer) of dimer for wild type and mutant forms of CD2. Attempts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results